Vertex Pharmaceuticals Operating Expenses 2010-2024 | VRTX
Vertex Pharmaceuticals operating expenses for the twelve months ending September 30, 2024 were $10.896B, a 88.61% increase year-over-year.
- Vertex Pharmaceuticals annual operating expenses for 2023 were $6.037B, a 30.58% increase from 2022.
- Vertex Pharmaceuticals annual operating expenses for 2022 were $4.623B, a 3.53% decline from 2021.
- Vertex Pharmaceuticals annual operating expenses for 2021 were $4.792B, a 43.08% increase from 2020.